Alqahtani et al
200
|
Saliva |
Cross‐sectional |
14 |
Elevated inflammatory cytokines, differential expression of metabolites |
Bustamante et al
64
|
Saliva |
Cross‐sectional |
16 |
Elevated levels of carcinogen N′‐nitrosonornicotine (NNN) |
Cichońska et al
205
|
Saliva |
Cross‐sectional |
40 |
Decreased lysozyme and increased lactoferrin, no difference in IgA |
Flieger et al
58
|
Saliva |
Cross‐sectional |
8 |
Elevated levels of thiocyanate |
Franco et al
171
|
Oral epithelial cells |
Cross‐sectional |
22 |
No significant increase in micronuclei |
Hamad et al
201
|
Buccal cells and blood |
Self‐controlled |
3 |
Differential gene expression |
Martin et al
202
|
Nasal epithelial cells |
Cross‐sectional |
12 |
Differential gene expression (especially suppression of immune‐related genes) |
Pushalkar et al
185
|
Saliva |
Cross‐sectional |
40 |
Altered oral microbiome, nonsignificant but considerable alterations in inflammatory cytokines |
Rebuli et al
203
|
Nasal epithelial cell |
Clinical trial |
15 |
Suppression of IgA in setting of viral inoculation, differential gene expression, differential cytokine levels |
Schwarzmeier et al
204
|
Oral epithelial cells |
Cross‐sectional |
20 |
Increased metanuclear abnormalities |
Stewart et al
206
|
Saliva and buccal swab |
Cross‐sectional |
10 |
No significant differences in oral microbiome |
Tommasi et al
199
|
Oral epithelial cells |
Cross‐sectional |
42 |
Differential gene expression |